This trial will test a new drug's safety & effectiveness in a controlled, randomized study. Results will help doctors decide best use.
- Acute Pain
1 Primary · 1 Secondary · Reporting Duration: From start of infusion to 72 hours post-infusion
2 Treatment Groups
1 of 2
1 of 2
56 Total Participants · 2 Treatment Groups
Primary Treatment: SBS-1000 · Has Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 59 · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment open for participants that are eighty years and above?
"This clinical trial can only accept patients between the ages of 18 and 59, as stated in its eligibility requirements." - Anonymous Online Contributor
Has the FDA sanctioned SBS-1000 for general use?
"As this is a Phase 1 clinical trial, the safety of SBS-1000 was given an initial rating of 1 due to lack of available data on efficacy and safety." - Anonymous Online Contributor
Is this experiment in need of participants at the moment?
"Clinicaltrials.gov confirms that this study is currently enrolling participants, with its first posting on 30 January 2023 and the most recent update being 31 January of the same year." - Anonymous Online Contributor
What is the scope of participants involved in this medical research?
"Yes, the information on clinicialtrials.gov indicates that this trial is actively enrolling patients. This study was first listed on January 30th 2023 and most recently updated on January 31st 2023. There are currently 56 participants being recruited from one location." - Anonymous Online Contributor
Who is eligible to take part in this research investigation?
"This clinical trial seeks 56 volunteers between 18 and 59 years old, who suffer from acute pain. Those hoping to participate should meet the following requirements: A signed informed consent form (ICF), BMI within 18-33 kg/m^2 range, At least 50kg body weight, Willingness to comply with study procedures; For female participants an acceptable contraceptive method must be used; For male participants an acceptable contraceptive method is required; Clinically healthy at screening and admission; Non- or ex-smokers." - Anonymous Online Contributor